1-15493007-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001229.5(CASP9):c.1187T>A(p.Ile396Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001229.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP9 | NM_001229.5 | c.1187T>A | p.Ile396Asn | missense_variant | 9/9 | ENST00000333868.10 | NP_001220.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP9 | ENST00000333868.10 | c.1187T>A | p.Ile396Asn | missense_variant | 9/9 | 1 | NM_001229.5 | ENSP00000330237 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251228Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135846
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461820Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 727218
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2023 | The c.1187T>A (p.I396N) alteration is located in exon 9 (coding exon 9) of the CASP9 gene. This alteration results from a T to A substitution at nucleotide position 1187, causing the isoleucine (I) at amino acid position 396 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at